Search Results - "Lochrin, C."

Clinical use of a commercial Monte Carlo treatment planning system for electron beams by Cygler, J E, Lochrin, C, Daskalov, G M, Howard, M, Zohr, R, Esche, B, Eapen, L, Grimard, L, Caudrelier, J M

“…In 2002 we fully implemented clinically a commercial Monte Carlo based treatment planning system for electron beams. The software, developed by MDS Nordion…”
Get more information

Sci—Wed PM: Delivery—02: Characterization and Clinical Evaluation of RADPOS 4D in vivo Dosimetry System by Cherpak, AJ, Cygler, JE, Andrusyk, S, Pantarotto, J, MacRae, R, Lochrin, C, Perry, G

“…A novel 4D in vivo dosimetry system, RADPOS, has recently been developed. The system combines a MOSFET dosimeter with an electromagnetic positioning sensor and…”
Get full text

121P CLINICAL EVALUATION OF A NOVEL 4D IN-VIVO DOSIMETRY SYSTEM FOR LUNG CANCER RADIOTHERAPY by Perry, G, Cherpak, A, Cygler, J.E, Andrusyk, S, Panarotto, J, Macrae, R, Lochrin, C

Get full text

Continuity clinics in oncology training programs in Canada by Croke, J M, Vickers, M M, E, C, Heng, D Y, Reaume, M N, Song, X, Meng, J, Asmis, T, Lochrin, C

“…Continuity clinics (ccs) give trainees an opportunity for longitudinal follow-up of a patient cohort. Trainees can function in a semi-autonomous manner and…”
Get full text

SU‐FF‐T‐287: Effect of Tissue Inhomogeneitis on MU Required to Deliver Prescribed Dose — Monte Carlo Study by Cygler, J, Berrang, T, Esche, B, Shokrani, P, Lochrin, C, Grimard, L

“…Purpose: The purpose of this study is to evaluate the effect of tissue inhomogeneities and surface irregularities on the value of monitor units, MU, calculated…”
Get full text

Right ventricular dysfunction in patients with COVID‐19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study by McCall, P. J., Willder, J. M., Stanley, B. L., Messow, C‐M., Allan, J., Gemmell, L., Puxty, A., Strachan, D., Berry, C., Shelley, B.G., Reece, A., Kitchen, C., Gillies, M., Dabek, V., Irvine, V., MacBrayne, J., Sim, K., Scott, T., Trumper, E., Savage, F., Allan, A., Falconer, J., Coutts, A., McDonald, A., Rutherford, J., Christie, D., Jardine, C., Hughes, M., Cathcart, S., Sim, M., Docking, B., Thornton, M., Greatorex, B., Rae, J., Barr, C., Bradley, C., Barrett, F., Campbell, R., Clarke, N., Mascarenhas, M., Matheson, J., McDonald, D., O'Hara, M., O'keeffe, L., Price, R., McHendry, M., McLaughlan, D., Herman, C., Elliot, H., Meehan, S., Finn, D., Brannan, G., Wood, S., Watson, T., Ross, K., Tatarkowska, N., Boyle, R., Lee, E., Morrison, A., Lucie, Pl, Lochrin, C., Clements, S., Vigni, D.

“…Summary Cardiovascular complications due to COVID‐19, such as right ventricular dysfunction, are common. The combination of acute respiratory distress…”
Get full text

Variations in the management and outcome of non-small cell lung cancer in Ontario by Mackillop, W J, Dixon, P, Zhou, Y, Ago, C T, Ege, G, Hodson, D I, Kotalik, J F, Lochrin, C, Paszat, L, Harris, D

“…Prospectively gathered information in the Ontario Cancer Foundation's computerized clinical database was analysed to provide a description of the management of…”
Get more information

Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report by Lochrin, C A, Wilson, G D, McNally, N J, Dische, S, Saunders, M I

“…The local tumor control achieved in patients treated in a pilot study of continuous, hyperfractionated, accelerated radiotherapy has been related to the tumor…”
Get more information

Right ventricular free wall longitudinal strain is independently associated with mortality in mechanically ventilated patients with COVID-19 by McErlane, James, McCall, Philip, Willder, Jennifer, Berry, Colin, Shelley, Ben

“…Background Right ventricular (RV) dysfunction has been commonly reported in patients with Coronavirus disease 2019 (COVID-19), and is associated with mortality…”
Get full text

Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15) by Bezjak, Andrea, Dixon, Peter, Brundage, Michael, Tu, Dong, Palmer, Michael J, Blood, Paul, Grafton, Clive, Lochrin, Catherine, Leong, Carson, Mulroy, Liam, Smith, Colum, Wright, James, Pater, Joseph L

“…This multi-institutional Phase III randomized study compared 10 Gy single-fraction radiotherapy (RT) with 20 Gy in five fractions in the palliation of thoracic…”
Get more information

Recent advances in the treatment of non-small cell lung cancer by Goss, G D, Dahrouge, S, Lochrin, C A

“…Non-small cell lung cancer (NSCLC), which represents the bulk of primary carcinomas of the lung, is an aggressive malignancy. The majority of patients with…”
Get more information

Continuous hyperfractionated accelerated radiotherapy in the treatment of carcinoma of the columella and vestibule of the nose by Turner, S.L., Lochrin, C.A., Dische, S., Saunders, M.I., Maher, E.J.

“…Twenty-one patients with squamous cell carcinoma of the nasal columella and vestibule were treated at the Mount Vernon Centre for Cancer Treatment between…”
Get full text

P-227 Concurrent chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer by Song, X., Gallant, V., Laurie, S., Nicholas, G., Reaume, N., MacRae, R., Agboola, O., Perry, G., Lochrin, C., Goss, G.

Get full text

Esthesioneuroblastoma by Lochrin, C

Get more information

Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors by Alsbeih, G, Malone, S, Lochrin, C, Girard, A, Fertil, B, Raaphorst, G P

“…To assess the relationship between fibroblast intrinsic radiosensitivity in vitro and late reactions of normal tissues in patients treated by definitive…”
Get more information

Characteristics of lung cancer patients entered on a Canadian palliative radiotherapy study (National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC.15 study) by Dixon, P, Brundage, M, Palmer, M, Zee, B, Peter, J, Leong, C, Mulroy, L, Wright, J, Grafton, C, Blood, P, Lochrin, C

Get full text

Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer by Lochrin, Catherine, Goss, Glenwood, Stewart, David J., Cross, Peter, Agboola, Olusegun, Dahrouge, Simone, Tomiak, Eva, Evans, W.K.

“…Objectives: We evaluated the effect of hyperfractionated accelerated radiotherapy combined with low dose radiosensitisers followed by standard dose…”
Get full text

168 A pilot study of high dose chemotherapy and irradiation with NEUPOGEN (G-CSF) in limited disease small cell lung cancer (SCLC) by Goss, G., Lochrin, C., Gertler, S., Stewart, Doug, Cross, P., Agboola, O., Stewart, David, Spadafora, S., Hewitt, A., Bociek, G., Evans, W., Yau, J.

Get full text

1100 Concurrent daily chemotherapy with hyperfractionated thoracic irradiation in stage IIIA & B NSCLC by Lochrin, C., Goss, G., Cross, P., Stewart, D., Tomiak, E., Agboola, O., Aref, I., Reid, K., Girard, A., Logan, D., Crepeau, A., Dahrouge, S., Evans, W.K.

“…In January 1993 we initiated a pilot study of concurrent daily chemotherapy with hyperfractionated thoracic irradiation in Stage III NSCLC. Twenty-four…”
Get full text

Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group by Logan, D M, Lochrin, C A, Darling, G, Eady, A, Newman, T E, Evans, W K

“…1) Does the use of postoperative, adjuvant radiotherapy or chemotherapy, alone or in combination, improve survival rates among patients with completely…”
Get more information